RAND CAPITAL CORPORATION (RAND) earnings per share

Annual history
Fiscal years 2023 – 2025
USD / SHARE 5 PERIODS
Period End Diluted Filed
FY 2025 2025-12-31 -$2.73 2026-03-05
FY 2024 2024-12-31 $3.42 2025-03-10
FY 2023 2023-12-31 $2.53 2024-03-05
FY 2023 2022-12-31 -$0.34 2024-03-05
FY 2023 2021-12-31 $6.12 2024-03-05
Quarterly history
Fiscal years 2023 – 2026
USD / SHARE 17 PERIODS
Period End Diluted Filed
Q1 2026 2026-03-31 -$0.12 2026-05-06
Q4 2025 2025-12-31 $0.37 2026-03-05
Q3 2025 2025-09-30 -$0.75 2025-11-07
Q2 2025 2025-06-30 -$2.60 2025-08-04
Q1 2025 2025-03-31 $0.29 2025-05-05
Q4 2024 2024-12-31 -$1.14 2025-03-10
Q3 2024 2024-09-30 $1.02 2024-11-06
Q2 2024 2024-06-30 $3.00 2024-08-06
Q1 2024 2024-03-31 $0.54 2024-05-13
Q4 2023 2023-12-31 $0.42 2024-03-05
Q3 2023 2023-09-30 $0.23 2023-11-06
Q2 2023 2023-06-30 $1.04 2023-08-04
Q1 2023 2023-03-31 $0.84 2023-05-09
Q4 2023 2022-12-31 $0.12 2024-03-05
Q3 2023 2022-09-30 $0.43 2023-11-06
Q2 2023 2022-06-30 -$0.73 2023-08-04
Q1 2023 2022-03-31 -$0.16 2023-05-09

Methodology

Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (6 split s since 1986).

For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.

RAND CIK 0000081955 Source: EDGAR filings · all facts

Related tickers

VRCA

Verrica Pharmaceuticals Inc.

DUKB

DUKE ENERGY CORPORATION

NCPL

NETCAPITAL INC.